A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation
Aims: To evaluate the evidence of therapeutic international normalised ratio (INR) control reporting and to provide recommendations for future reporting, particularly for research and audit purposes. Methods: A systematic review of literature published over a five year period describing therapeutic...
Gespeichert in:
Veröffentlicht in: | Journal of clinical pathology 2003-01, Vol.56 (1), p.48-51 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 51 |
---|---|
container_issue | 1 |
container_start_page | 48 |
container_title | Journal of clinical pathology |
container_volume | 56 |
creator | Fitzmaurice, D A Kesteven, P Gee, K M Murray, E T McManus, R |
description | Aims: To evaluate the evidence of therapeutic international normalised ratio (INR) control reporting and to provide recommendations for future reporting, particularly for research and audit purposes. Methods: A systematic review of literature published over a five year period describing therapeutic INR control. Papers were identified from the Medline electronic database, and those that met the quality criteria were reviewed independently by an academic general practitioner and a consultant haematologist. Results: Fifteen papers were identified that met the quality criteria for review. The sample size of studies ranged from 53 to 2545 (mean, 483.9) patients. Follow up ranged from three months to 13 years. Twelve studies reported results from secondary care only, one from primary care only, and two from both primary and secondary care. Seven of the 15 papers reported percentage time in range, five of 15 papers reported mean INR, six of 15 papers reported the proportion of tests in range, and five of 15 papers reported mean warfarin dose. Additional methods of presenting INR results were: dose changes each month, distribution of INR results, deviation of INR value from mean, percentage dose changes, time between visits, and median INR value. Six papers reported only one outcome measure, six reported two outcomes, two papers reported three outcomes, and one paper reported five outcomes. Conclusions: It is recommended that at least two outcome measures should be reported and measures should be selected so that both the INR determinations and dosing advice are monitored. |
doi_str_mv | 10.1136/jcp.56.1.48 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1769863</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A96693678</galeid><sourcerecordid>A96693678</sourcerecordid><originalsourceid>FETCH-LOGICAL-b645t-e165a04c95b85db64ed277bb81a5d254e57b8124755ba7010b1098554a5acf333</originalsourceid><addsrcrecordid>eNp9kt-L1DAQx4so3nr65LsURF-0a6b51b4Iy3L-gENBdF9Dmk73UttmTdr17r83dZdblUNCSJj5zHd-MEnyFMgSgIo3rdktuVjCkhX3kgUwmWcMmLifLAjJISslE2fJoxBaQoBKoA-TM8hZWTJKF0m7SsNNGLHXozWpx73Fn6lrUjeNxvWY9qjD5DFE1875Eeu0cT4dr3C-Xu9wmuOwadCMdo8DhvA73Osu1UP0Ob2duijuhsfJg0Z3AZ8c3_Pk27uLr-sP2eXn9x_Xq8usEoyPGYLgmjBT8qrgdbRhnUtZVQVoXuecIZfxnzPJeaUlAVIBKQvOmebaNJTS8-TtQXc3VT3WBocxVqN23vba3yinrfrbM9grtXV7BVKUhZgFXh4FvPsxYRhVb4PBrtMDuikomRdFCYxE8Pk_YOsmP8TmolYBACLnRaReH6it7lDZoXExq9nGWcXkbsDGRvOqFKKkQs54dgceT419HOcd_KsDb7wLwWNz2ykQNS-IiguiuFCg2Ew_-3M4J_a4ERF4cQR0MLprvB6MDSeOcZaXnJzKtHF7rm_92n9XQlLJ1afNWtENywX5ItTmNNSqb_9b4S_OtuA_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781116258</pqid></control><display><type>article</type><title>A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Fitzmaurice, D A ; Kesteven, P ; Gee, K M ; Murray, E T ; McManus, R</creator><creatorcontrib>Fitzmaurice, D A ; Kesteven, P ; Gee, K M ; Murray, E T ; McManus, R</creatorcontrib><description>Aims: To evaluate the evidence of therapeutic international normalised ratio (INR) control reporting and to provide recommendations for future reporting, particularly for research and audit purposes. Methods: A systematic review of literature published over a five year period describing therapeutic INR control. Papers were identified from the Medline electronic database, and those that met the quality criteria were reviewed independently by an academic general practitioner and a consultant haematologist. Results: Fifteen papers were identified that met the quality criteria for review. The sample size of studies ranged from 53 to 2545 (mean, 483.9) patients. Follow up ranged from three months to 13 years. Twelve studies reported results from secondary care only, one from primary care only, and two from both primary and secondary care. Seven of the 15 papers reported percentage time in range, five of 15 papers reported mean INR, six of 15 papers reported the proportion of tests in range, and five of 15 papers reported mean warfarin dose. Additional methods of presenting INR results were: dose changes each month, distribution of INR results, deviation of INR value from mean, percentage dose changes, time between visits, and median INR value. Six papers reported only one outcome measure, six reported two outcomes, two papers reported three outcomes, and one paper reported five outcomes. Conclusions: It is recommended that at least two outcome measures should be reported and measures should be selected so that both the INR determinations and dosing advice are monitored.</description><identifier>ISSN: 0021-9746</identifier><identifier>EISSN: 1472-4146</identifier><identifier>DOI: 10.1136/jcp.56.1.48</identifier><identifier>PMID: 12499433</identifier><identifier>CODEN: JCPAAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><subject>Administration, Oral ; Adult ; Anticoagulants ; Anticoagulants (Medicine) ; Anticoagulants - therapeutic use ; Biological and medical sciences ; Blood coagulation ; Cardiac arrhythmia ; Child ; Coagulation ; Dosage and administration ; Drug Administration Schedule ; Evaluation ; Follow-Up Studies ; Humans ; INR control ; International Normalized Ratio ; Investigative techniques, diagnostic techniques (general aspects) ; Medical sciences ; Mortality ; Oral medication ; Original ; Patient outcomes ; Prevention ; Stroke (Disease) ; Studies ; systematic review ; Treatment Outcome ; United Kingdom ; warfarin</subject><ispartof>Journal of clinical pathology, 2003-01, Vol.56 (1), p.48-51</ispartof><rights>Copyright 2003 Journal of Clinical Pathology</rights><rights>2003 INIST-CNRS</rights><rights>COPYRIGHT 2003 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2003 Copyright 2003 Journal of Clinical Pathology</rights><rights>Copyright © Copyright 2003 Journal of Clinical Pathology 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b645t-e165a04c95b85db64ed277bb81a5d254e57b8124755ba7010b1098554a5acf333</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769863/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769863/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14542950$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12499433$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fitzmaurice, D A</creatorcontrib><creatorcontrib>Kesteven, P</creatorcontrib><creatorcontrib>Gee, K M</creatorcontrib><creatorcontrib>Murray, E T</creatorcontrib><creatorcontrib>McManus, R</creatorcontrib><title>A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation</title><title>Journal of clinical pathology</title><addtitle>J Clin Pathol</addtitle><description>Aims: To evaluate the evidence of therapeutic international normalised ratio (INR) control reporting and to provide recommendations for future reporting, particularly for research and audit purposes. Methods: A systematic review of literature published over a five year period describing therapeutic INR control. Papers were identified from the Medline electronic database, and those that met the quality criteria were reviewed independently by an academic general practitioner and a consultant haematologist. Results: Fifteen papers were identified that met the quality criteria for review. The sample size of studies ranged from 53 to 2545 (mean, 483.9) patients. Follow up ranged from three months to 13 years. Twelve studies reported results from secondary care only, one from primary care only, and two from both primary and secondary care. Seven of the 15 papers reported percentage time in range, five of 15 papers reported mean INR, six of 15 papers reported the proportion of tests in range, and five of 15 papers reported mean warfarin dose. Additional methods of presenting INR results were: dose changes each month, distribution of INR results, deviation of INR value from mean, percentage dose changes, time between visits, and median INR value. Six papers reported only one outcome measure, six reported two outcomes, two papers reported three outcomes, and one paper reported five outcomes. Conclusions: It is recommended that at least two outcome measures should be reported and measures should be selected so that both the INR determinations and dosing advice are monitored.</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Anticoagulants</subject><subject>Anticoagulants (Medicine)</subject><subject>Anticoagulants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood coagulation</subject><subject>Cardiac arrhythmia</subject><subject>Child</subject><subject>Coagulation</subject><subject>Dosage and administration</subject><subject>Drug Administration Schedule</subject><subject>Evaluation</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>INR control</subject><subject>International Normalized Ratio</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Oral medication</subject><subject>Original</subject><subject>Patient outcomes</subject><subject>Prevention</subject><subject>Stroke (Disease)</subject><subject>Studies</subject><subject>systematic review</subject><subject>Treatment Outcome</subject><subject>United Kingdom</subject><subject>warfarin</subject><issn>0021-9746</issn><issn>1472-4146</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kt-L1DAQx4so3nr65LsURF-0a6b51b4Iy3L-gENBdF9Dmk73UttmTdr17r83dZdblUNCSJj5zHd-MEnyFMgSgIo3rdktuVjCkhX3kgUwmWcMmLifLAjJISslE2fJoxBaQoBKoA-TM8hZWTJKF0m7SsNNGLHXozWpx73Fn6lrUjeNxvWY9qjD5DFE1875Eeu0cT4dr3C-Xu9wmuOwadCMdo8DhvA73Osu1UP0Ob2duijuhsfJg0Z3AZ8c3_Pk27uLr-sP2eXn9x_Xq8usEoyPGYLgmjBT8qrgdbRhnUtZVQVoXuecIZfxnzPJeaUlAVIBKQvOmebaNJTS8-TtQXc3VT3WBocxVqN23vba3yinrfrbM9grtXV7BVKUhZgFXh4FvPsxYRhVb4PBrtMDuikomRdFCYxE8Pk_YOsmP8TmolYBACLnRaReH6it7lDZoXExq9nGWcXkbsDGRvOqFKKkQs54dgceT419HOcd_KsDb7wLwWNz2ykQNS-IiguiuFCg2Ew_-3M4J_a4ERF4cQR0MLprvB6MDSeOcZaXnJzKtHF7rm_92n9XQlLJ1afNWtENywX5ItTmNNSqb_9b4S_OtuA_</recordid><startdate>200301</startdate><enddate>200301</enddate><creator>Fitzmaurice, D A</creator><creator>Kesteven, P</creator><creator>Gee, K M</creator><creator>Murray, E T</creator><creator>McManus, R</creator><general>BMJ Publishing Group Ltd and Association of Clinical Pathologists</general><general>BMJ</general><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>Copyright 2003 Journal of Clinical Pathology</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200301</creationdate><title>A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation</title><author>Fitzmaurice, D A ; Kesteven, P ; Gee, K M ; Murray, E T ; McManus, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b645t-e165a04c95b85db64ed277bb81a5d254e57b8124755ba7010b1098554a5acf333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Anticoagulants</topic><topic>Anticoagulants (Medicine)</topic><topic>Anticoagulants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood coagulation</topic><topic>Cardiac arrhythmia</topic><topic>Child</topic><topic>Coagulation</topic><topic>Dosage and administration</topic><topic>Drug Administration Schedule</topic><topic>Evaluation</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>INR control</topic><topic>International Normalized Ratio</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Oral medication</topic><topic>Original</topic><topic>Patient outcomes</topic><topic>Prevention</topic><topic>Stroke (Disease)</topic><topic>Studies</topic><topic>systematic review</topic><topic>Treatment Outcome</topic><topic>United Kingdom</topic><topic>warfarin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fitzmaurice, D A</creatorcontrib><creatorcontrib>Kesteven, P</creatorcontrib><creatorcontrib>Gee, K M</creatorcontrib><creatorcontrib>Murray, E T</creatorcontrib><creatorcontrib>McManus, R</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fitzmaurice, D A</au><au>Kesteven, P</au><au>Gee, K M</au><au>Murray, E T</au><au>McManus, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation</atitle><jtitle>Journal of clinical pathology</jtitle><addtitle>J Clin Pathol</addtitle><date>2003-01</date><risdate>2003</risdate><volume>56</volume><issue>1</issue><spage>48</spage><epage>51</epage><pages>48-51</pages><issn>0021-9746</issn><eissn>1472-4146</eissn><coden>JCPAAK</coden><abstract>Aims: To evaluate the evidence of therapeutic international normalised ratio (INR) control reporting and to provide recommendations for future reporting, particularly for research and audit purposes. Methods: A systematic review of literature published over a five year period describing therapeutic INR control. Papers were identified from the Medline electronic database, and those that met the quality criteria were reviewed independently by an academic general practitioner and a consultant haematologist. Results: Fifteen papers were identified that met the quality criteria for review. The sample size of studies ranged from 53 to 2545 (mean, 483.9) patients. Follow up ranged from three months to 13 years. Twelve studies reported results from secondary care only, one from primary care only, and two from both primary and secondary care. Seven of the 15 papers reported percentage time in range, five of 15 papers reported mean INR, six of 15 papers reported the proportion of tests in range, and five of 15 papers reported mean warfarin dose. Additional methods of presenting INR results were: dose changes each month, distribution of INR results, deviation of INR value from mean, percentage dose changes, time between visits, and median INR value. Six papers reported only one outcome measure, six reported two outcomes, two papers reported three outcomes, and one paper reported five outcomes. Conclusions: It is recommended that at least two outcome measures should be reported and measures should be selected so that both the INR determinations and dosing advice are monitored.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Association of Clinical Pathologists</pub><pmid>12499433</pmid><doi>10.1136/jcp.56.1.48</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9746 |
ispartof | Journal of clinical pathology, 2003-01, Vol.56 (1), p.48-51 |
issn | 0021-9746 1472-4146 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1769863 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Administration, Oral Adult Anticoagulants Anticoagulants (Medicine) Anticoagulants - therapeutic use Biological and medical sciences Blood coagulation Cardiac arrhythmia Child Coagulation Dosage and administration Drug Administration Schedule Evaluation Follow-Up Studies Humans INR control International Normalized Ratio Investigative techniques, diagnostic techniques (general aspects) Medical sciences Mortality Oral medication Original Patient outcomes Prevention Stroke (Disease) Studies systematic review Treatment Outcome United Kingdom warfarin |
title | A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T22%3A55%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20systematic%20review%20of%20outcome%20measures%20reported%20for%20the%20therapeutic%20effectiveness%20of%20oral%20anticoagulation&rft.jtitle=Journal%20of%20clinical%20pathology&rft.au=Fitzmaurice,%20D%20A&rft.date=2003-01&rft.volume=56&rft.issue=1&rft.spage=48&rft.epage=51&rft.pages=48-51&rft.issn=0021-9746&rft.eissn=1472-4146&rft.coden=JCPAAK&rft_id=info:doi/10.1136/jcp.56.1.48&rft_dat=%3Cgale_pubme%3EA96693678%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781116258&rft_id=info:pmid/12499433&rft_galeid=A96693678&rfr_iscdi=true |